BCHE and early-onset autosomal dominant Alzheimer disease: Methylphenidate, another stimulant, was infrequently used, and unsurprisingly almost no respondents used cholinesterase inhibitors or glutamate regulators, commonly prescribed for Alzheimer’s disease and dementia.